Skip to contentK
Kyntra Bio, Inc.
K
KYNBKyntra Bio, Inc. Q2 2018 · 10-Q
Revenue$43.95M$43.95M+45.2% vs Q2 2017 Net Income-$23.42M-$23.42MN/M vs Q2 2017 EPS Diluted-$0.28-$0.28N/M vs Q2 2017 Operating Income-$23,241,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$36,832,000N/M Margins · derivedOperating margin-52.9%+46.7 pt vs Q2 2017
Net margin-53.3%+52.1 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 7, 2018 · 38 d after period end